Identification of novel DNA methylation markers in cervical cancer

Hung Cheng Lai, Ya Wen Lin, Tim H M Huang, Pearlly Yan, Rui Lan Huang, Hui Chen Wang, Joseph Liu, Michael W Y Chan, Tang Yuan Chu, Chien An Sun, Cheng Chang, Mu Hsien Yu

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Testing for DNA methylation has potential in cancer screening. Most previous studies of DNA methylation in cervical cancer used a candidate gene approach. The aim our study was to identify novel genes that are methylated in cervical cancers and to test their potential in clinical applications. We did a differential methylation hybridization using a CpG island (CGI) microarray containing 8640 CGI tags to uncover methylated genes in squamous cell carcinomas (SCC) of the uterine cervix. Pooled DNA from cancer tissues and normal cervical swabs were used for comparison. Methylation-specific polymerase chain reaction, bisulfite sequencing and reverse transcription polymerase chain reaction were used to confirm the methylation status in cell lines, normal cervices (n = 45), low-grade lesions (n = 45), high-grade lesions (HSIL; n = 58) and invasive squamous cell carcinomas (SCC; n = 22 from swabs and n = 109 from tissues). Human papillomavirus (HPV) was detected using reverse line blots. We reported 6 genes (SOX1, PAX1, LMX1A, NKX6-1, WT1 and ONECUT1) more frequently methylated in SCC tissues (81.5, 94.4, 89.9, 80.4, 77.8 and 20.4%, respectively) than in their normal controls (2.2, 0, 6.7, 11.9, 11.1 and 0%, respectively; p <0.0001). Parallel testing of HPV and PAXl methylation in cervical swabs confers an improved sensitivity than HPV testing alone (80% vs. 66%) without compromising specificity (63% vs. 64%) for HSIL/SCC. Testing PAXl methylation marker alone, the specificity for HSIL/SCC is 99%. The analysis of these novel DNA methylations may be a promising approach for the screening of cervical cancers.

Original languageEnglish
Pages (from-to)161-167
Number of pages7
JournalInternational Journal of Cancer
Volume123
Issue number1
DOIs
Publication statusPublished - Jul 1 2008
Externally publishedYes

Fingerprint

DNA Methylation
Genetic Markers
Uterine Cervical Neoplasms
Squamous Cell Carcinoma
Methylation
CpG Islands
Cervix Uteri
Genes
Polymerase Chain Reaction
Early Detection of Cancer
Reverse Transcription
Cell Line
DNA
Neoplasms

Keywords

  • Cervical cancer
  • Epigenetics
  • Hpv
  • Methylation
  • Microarray

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Identification of novel DNA methylation markers in cervical cancer. / Lai, Hung Cheng; Lin, Ya Wen; Huang, Tim H M; Yan, Pearlly; Huang, Rui Lan; Wang, Hui Chen; Liu, Joseph; Chan, Michael W Y; Chu, Tang Yuan; Sun, Chien An; Chang, Cheng; Yu, Mu Hsien.

In: International Journal of Cancer, Vol. 123, No. 1, 01.07.2008, p. 161-167.

Research output: Contribution to journalArticle

Lai, HC, Lin, YW, Huang, THM, Yan, P, Huang, RL, Wang, HC, Liu, J, Chan, MWY, Chu, TY, Sun, CA, Chang, C & Yu, MH 2008, 'Identification of novel DNA methylation markers in cervical cancer', International Journal of Cancer, vol. 123, no. 1, pp. 161-167. https://doi.org/10.1002/ijc.23519
Lai, Hung Cheng ; Lin, Ya Wen ; Huang, Tim H M ; Yan, Pearlly ; Huang, Rui Lan ; Wang, Hui Chen ; Liu, Joseph ; Chan, Michael W Y ; Chu, Tang Yuan ; Sun, Chien An ; Chang, Cheng ; Yu, Mu Hsien. / Identification of novel DNA methylation markers in cervical cancer. In: International Journal of Cancer. 2008 ; Vol. 123, No. 1. pp. 161-167.
@article{275cf641c4fc44b9a1f82a672e5e5193,
title = "Identification of novel DNA methylation markers in cervical cancer",
abstract = "Testing for DNA methylation has potential in cancer screening. Most previous studies of DNA methylation in cervical cancer used a candidate gene approach. The aim our study was to identify novel genes that are methylated in cervical cancers and to test their potential in clinical applications. We did a differential methylation hybridization using a CpG island (CGI) microarray containing 8640 CGI tags to uncover methylated genes in squamous cell carcinomas (SCC) of the uterine cervix. Pooled DNA from cancer tissues and normal cervical swabs were used for comparison. Methylation-specific polymerase chain reaction, bisulfite sequencing and reverse transcription polymerase chain reaction were used to confirm the methylation status in cell lines, normal cervices (n = 45), low-grade lesions (n = 45), high-grade lesions (HSIL; n = 58) and invasive squamous cell carcinomas (SCC; n = 22 from swabs and n = 109 from tissues). Human papillomavirus (HPV) was detected using reverse line blots. We reported 6 genes (SOX1, PAX1, LMX1A, NKX6-1, WT1 and ONECUT1) more frequently methylated in SCC tissues (81.5, 94.4, 89.9, 80.4, 77.8 and 20.4{\%}, respectively) than in their normal controls (2.2, 0, 6.7, 11.9, 11.1 and 0{\%}, respectively; p <0.0001). Parallel testing of HPV and PAXl methylation in cervical swabs confers an improved sensitivity than HPV testing alone (80{\%} vs. 66{\%}) without compromising specificity (63{\%} vs. 64{\%}) for HSIL/SCC. Testing PAXl methylation marker alone, the specificity for HSIL/SCC is 99{\%}. The analysis of these novel DNA methylations may be a promising approach for the screening of cervical cancers.",
keywords = "Cervical cancer, Epigenetics, Hpv, Methylation, Microarray",
author = "Lai, {Hung Cheng} and Lin, {Ya Wen} and Huang, {Tim H M} and Pearlly Yan and Huang, {Rui Lan} and Wang, {Hui Chen} and Joseph Liu and Chan, {Michael W Y} and Chu, {Tang Yuan} and Sun, {Chien An} and Cheng Chang and Yu, {Mu Hsien}",
year = "2008",
month = "7",
day = "1",
doi = "10.1002/ijc.23519",
language = "English",
volume = "123",
pages = "161--167",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Identification of novel DNA methylation markers in cervical cancer

AU - Lai, Hung Cheng

AU - Lin, Ya Wen

AU - Huang, Tim H M

AU - Yan, Pearlly

AU - Huang, Rui Lan

AU - Wang, Hui Chen

AU - Liu, Joseph

AU - Chan, Michael W Y

AU - Chu, Tang Yuan

AU - Sun, Chien An

AU - Chang, Cheng

AU - Yu, Mu Hsien

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Testing for DNA methylation has potential in cancer screening. Most previous studies of DNA methylation in cervical cancer used a candidate gene approach. The aim our study was to identify novel genes that are methylated in cervical cancers and to test their potential in clinical applications. We did a differential methylation hybridization using a CpG island (CGI) microarray containing 8640 CGI tags to uncover methylated genes in squamous cell carcinomas (SCC) of the uterine cervix. Pooled DNA from cancer tissues and normal cervical swabs were used for comparison. Methylation-specific polymerase chain reaction, bisulfite sequencing and reverse transcription polymerase chain reaction were used to confirm the methylation status in cell lines, normal cervices (n = 45), low-grade lesions (n = 45), high-grade lesions (HSIL; n = 58) and invasive squamous cell carcinomas (SCC; n = 22 from swabs and n = 109 from tissues). Human papillomavirus (HPV) was detected using reverse line blots. We reported 6 genes (SOX1, PAX1, LMX1A, NKX6-1, WT1 and ONECUT1) more frequently methylated in SCC tissues (81.5, 94.4, 89.9, 80.4, 77.8 and 20.4%, respectively) than in their normal controls (2.2, 0, 6.7, 11.9, 11.1 and 0%, respectively; p <0.0001). Parallel testing of HPV and PAXl methylation in cervical swabs confers an improved sensitivity than HPV testing alone (80% vs. 66%) without compromising specificity (63% vs. 64%) for HSIL/SCC. Testing PAXl methylation marker alone, the specificity for HSIL/SCC is 99%. The analysis of these novel DNA methylations may be a promising approach for the screening of cervical cancers.

AB - Testing for DNA methylation has potential in cancer screening. Most previous studies of DNA methylation in cervical cancer used a candidate gene approach. The aim our study was to identify novel genes that are methylated in cervical cancers and to test their potential in clinical applications. We did a differential methylation hybridization using a CpG island (CGI) microarray containing 8640 CGI tags to uncover methylated genes in squamous cell carcinomas (SCC) of the uterine cervix. Pooled DNA from cancer tissues and normal cervical swabs were used for comparison. Methylation-specific polymerase chain reaction, bisulfite sequencing and reverse transcription polymerase chain reaction were used to confirm the methylation status in cell lines, normal cervices (n = 45), low-grade lesions (n = 45), high-grade lesions (HSIL; n = 58) and invasive squamous cell carcinomas (SCC; n = 22 from swabs and n = 109 from tissues). Human papillomavirus (HPV) was detected using reverse line blots. We reported 6 genes (SOX1, PAX1, LMX1A, NKX6-1, WT1 and ONECUT1) more frequently methylated in SCC tissues (81.5, 94.4, 89.9, 80.4, 77.8 and 20.4%, respectively) than in their normal controls (2.2, 0, 6.7, 11.9, 11.1 and 0%, respectively; p <0.0001). Parallel testing of HPV and PAXl methylation in cervical swabs confers an improved sensitivity than HPV testing alone (80% vs. 66%) without compromising specificity (63% vs. 64%) for HSIL/SCC. Testing PAXl methylation marker alone, the specificity for HSIL/SCC is 99%. The analysis of these novel DNA methylations may be a promising approach for the screening of cervical cancers.

KW - Cervical cancer

KW - Epigenetics

KW - Hpv

KW - Methylation

KW - Microarray

UR - http://www.scopus.com/inward/record.url?scp=43949142803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949142803&partnerID=8YFLogxK

U2 - 10.1002/ijc.23519

DO - 10.1002/ijc.23519

M3 - Article

C2 - 18398837

AN - SCOPUS:43949142803

VL - 123

SP - 161

EP - 167

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -